Back to search
Allogeneic Haematopoietic Stem Cell Transplantation
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Allogeneic Haematopoietic Stem Cell Transplantation trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Allogeneic Haematopoietic Stem Cell Transplantation trials you may qualify forBackground: Allogeneic hematopoietic stem cell transplant involves taking blood stem cells from a donor and giving them to a recipient. The transplants are use…
This study is a prospective, multicenter, open-label, phase II clinical trial designed to evaluate the safety and efficacy of moxibustion in patients with stero…
The purpose of this study is to evaluate the efficacy and safety of a personalized strategy for discontinuing Letermovir (a drug used to prevent Cytomegalovirus…
Invasive fungal disease (IFD) is one of the serious complications after hematopoietic stem cell transplantation (HSCT), characterized by high incidence and high…
Background: Chronic granulomatous disease (CGD) affects the immune system. People with CGD are more likely to get infections. Drugs can help control infections…
A multi-centre phase II trial of GvHD prophylaxis following unrelated donor stem cell transplantation comparing Thymoglobulin vs. Calcineurin inhibitor or Sirol…
The standard treatment for acute graft-vs-host disease (GVHD) is to suppress the activity of the donor immune cells using steroid medications such as prednisone…
This is a prospective, single-center, observational study to evaluate the efficacy and safety of salvage haploidentical allogeneic hematopoietic stem cell trans…
This study will evaluate the long-term functional status, psychosocial adjustment and quality of life of patients with different types of diseases and condition…